Madhukar H. Trivedi, MD, Presenter
Betty Jo Hay Distinguished Chair in Mental Health
Professor of Psychiatry
Director Comprehensive Center for Depression
Department of Psychiatry
University of Texas Southwestern Medical Center
Consulting: Madhukar H. Trivedi is or has been an advisor/consultant to, Alkermes, AstraZeneca, Bristol-Myers Squibb Company, Cephalon, Inc., Cerecor, Concert Pharmaceuticals, Inc., Eli Lilly & Company, Evotec, Forest Pharmaceuticals, GlaxoSmithKline, Janssen Global Services, LLC/Janssen Pharmaceutica Products, LP/Johnson & Johnson PRD, Lundbeck, MedAvante, Medtronic, Merck, Mitsubishi Tanabe Pharma Development America, Inc., Naurex, Neuronetics, Otsuka Pharmaceuticals, Pamlab, Pfizer Inc., Phoenix Marketing Solutions, Rexahn Pharmaceuticals, Ridge Diagnostics, Roche Products Ltd ., Sepracor, SHIRE Development, Sunovion, Takeda, Vivus, and Wyeth-Ayerst Laboratories.
Research Activities: In addition, he has received research support from: Agency for Healthcare Research and Quality (AHRQ), National Alliance for Research in Schizophrenia and Depression, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Diabetes and Digestive Disorders.
Formal Advisory: Member, Scientific Advisory Board for the Canadian Biomarker Integration Network for Depression (CAN BIND) project (2014). Special Emphasis Panel, ZMH1 ERB – I (04), National Institute of Mental Health (NIMH), Mentored Career Development Award to Build Research Capacity in Global Mental Health, April 9, 2014.